Global Precision Nutrition Market - 2025-2033

Global precision nutrition market size reached US$ 6.78 billion in 2024 and is expected to reach US$ 22.82 billion by 2032, growing with a CAGR of 16.38% during the forecast period 2025-2032.

The global precision nutrition industry is experiencing substantial expansion driven by an increase in consumer demand for individualized health and wellness solutions. The growing recognition of nutrition's role in illness prevention, along with the global transition to preventive healthcare, has established precision nutrition as a feasible long-term option. The amalgamation of artificial intelligence and sophisticated analytics with genetic and biomarker testing is augmenting the scalability and efficacy of dietary recommendations.

As healthcare expenses rise, consumers are adopting proactive, individualized approaches for illness management and wellbeing enhancement. Strategic partnerships among technology providers, healthcare experts, and nutrition firms are further influencing the competitive environment.

Viome and Thorne are at the forefront of AI-driven platforms that provide data-informed insights and tailored nutritional treatments. The market's growth is further bolstered by the growing acceptance in emerging economies, particularly in Asia-Pacific, where rising disposable incomes and heightened health awareness persistently drive demand for customized nutrition services.

Precision Nutrition Market Trend

Technological advancements are a pivotal trend redefining the precision nutrition sector. Cutting-edge genetic testing, biomarker evaluation, and AI-driven instruments now offer highly individualized nutritional guidance. Viome has an always evolving AI engine that evaluates microbiome data, health feedback, and external variables to provide individualized health ratings and suggestions.

Thorne use extensive knowledge graphs and neural networks to analyze billions of biological data points, providing comprehensive and predictive health insights. Moreover, microbiome-oriented nutrition and personalized supplements are emerging as significant trends, facilitating dietary choices that correspond with gastrointestinal health and metabolic requirements.

The integration of digital health is propelling this trend; mobile health application downloads reached 3.2 billion in 2023, with nutrition-centric applications comprising 23% of the total. The advancement of wearable technology and real-time biomarker monitoring has made it possible to provide immediate, accurate recommendations. These technologies enhance user experience and promote sustained engagement with nutritional therapies.

Global Precision Nutrition Market Dynamics

Individualized Health Requirements and Preventive Emphasis Expansion of the Fuel Market

Multiple reasons are driving the expansion of the precision nutrition industry. The primary factor is the rising consumer desire for personalized health measures, driven by the increasing incidence of chronic diseases. By 2023, 45% of the 12 million persons in North America who underwent genetic testing did so to acquire nutrition-specific health insights. This indicates a robust connection between nutrigenomics and dietary selections.

Moreover, AI-driven systems are improving accessibility and precision in tailoring suggestions based on genetic and biomarker data. Preventive healthcare is increasingly popular as customers aim to reduce future medical costs. The amalgamation of AI with health monitoring instruments facilitates this transition by providing anticipatory dietary recommendations.

Strategic alliances among healthcare, technology, and nutrition sectors are enhancing the provision of integrated and efficient solutions. The emergence of microbiome-based goods and the efficacy of customized supplements demonstrate the growing confidence customers have in data-driven, scientifically validated health enhancement.

Elevated Testing Expenses Present an Obstacle to Widespread Adoption

The precision nutrition market encounters considerable obstacles owing to elevated testing expenses. The examination of genetic material and biomarkers necessitates advanced equipment and skilled interpretation, resulting in increased consumer costs. The expenses are transferred via costly at-home test kits and customized supplement programs, rendering them unattainable for price-sensitive consumers, especially in developing economies.

Subscription-based models, although providing continuous value, increase the overall expense over time, and numerous services are not reimbursed by health insurance. In areas characterized by significant income disparity, such as certain countries in Asia, elevated prices restrict market penetration and scalability.

To achieve widespread adoption, firms must prioritize the development of cost-reduction initiatives and scalable platforms. In the absence of this, the complete potential of precision nutrition may be restricted to affluent demographics, hence constraining its public health influence and impeding development in neglected areas. Ensuring the affordability of tailored nutrition is essential for achieving equitable health innovation worldwide.

Segment Analysis

The global precision nutrition market is segmented based on technology, platform type, application, end-user and region.

Precision Nutrition Enhances Chronic Disease Management with Customized Dietary Approaches

The disease management sector is anticipated to have the most significant growth in the precision nutrition market, propelled by the increasing implementation of individualized dietary approaches to tackle chronic and lifestyle-related health issues. Precision nutrition facilitates tailored advice for ailments including diabetes, cardiovascular diseases, obesity, and gastrointestinal disorders by utilizing genetic, biomarker, and lifestyle information.

Progress in artificial intelligence, genetics, and microbiome analysis has markedly improved the creation of customized treatments that better patient outcomes. These breakthroughs offer profound insights into individual metabolic reactions and microbiome makeup, enhancing the precision and efficacy of nutritional therapies.

The changing healthcare environment highlights the importance of preventative care, resulting in a heightened demand for individualized nutrition as a crucial component of disease management strategies. Moreover, digital health platforms facilitate the real-time monitoring of disease-specific biomarkers, allowing healthcare professionals to assess the efficacy of dietary modifications in conjunction with medical therapies. This integration positions illness management as a fundamental component in the advancement of precision nutrition.

Geographical Penetration

The Asia Pacific Region has Emerged as a Hub for the Growth of Precision Nutrition

The Asia Pacific area is the most rapidly expanding sector in the precision nutrition industry, driven by increasing health consciousness, technological advancements, and a burgeoning middle-class demographic. By 2030, the middle class is expected to comprise 3.5 billion individuals, 65% of the world population, thereby increasing the demand for tailored nutrition. Between 2020 and 2023, discretionary health and wellness expenditures in Asia increased by 8.5% per annum, as reported by the Asian Development Bank.

In 2023, smartphone penetration reached 68%, and downloads of health-related applications increased by 34% year-over-year, with 72% of urban consumers utilizing at least one digital tool for nutrition tracking. Chronic conditions like diabetes are increasing demand; Asia comprises 60% of the worldwide diabetic population, with associated healthcare expenditures anticipated to reach $200 billion in 2023.

Government investments enhance market potential—Japan designated $2.8 billion for personalized healthcare in 2024, while Singapore earmarked SGD 400 million for nutrition counseling. Organizations such as GeneQuest, AMILI, and Xcode Life are leading innovation by providing culturally tailored, affordable, and technology-driven solutions.

Sustainability Analysis

Sustainable innovation is emerging as a fundamental component in the advancement of precision nutrition, as enterprises strive to mitigate environmental effects while promoting long-term health equity. The growing dependence on digital technology, including AI and biomarker-based applications, diminishes the necessity for resource-intensive procedures and in-person consultations, thereby reducing the carbon footprint of healthcare delivery.

Moreover, as companies expand personalized nutrition via mobile platforms and at-home kits, they are integrating packaging innovation and recyclable materials to improve environmental sustainability. The sustainable procurement of components for customized supplements and functional foods is increasingly a priority for leading companies. Cost continues to impede access; yet, the pursuit of affordability coincides with sustainability by promoting efficient operations and reducing waste.

The emergence of microbiome-centric goods and digital health monitoring diminishes systemic resource utilization by prioritizing prevention rather than cure. With increasing consumer awareness, sustainability—both ecological and economic—is poised to become a fundamental principle in the continuous advancement of precision nutrition.

Competitive Landscape

The major global players in the market include Viome Life Sciences, Thorne HealthTech, Habit, DayTwo, Nutrigenomix, InsideTracker, Care/of, Persona Nutrition, Xcode Life, 23andMe

Key Developments
• In September 2024, Inside Tracker launched Nutrition DeepDive, a novel app-based tracker aimed at synchronizing nutrition with individualized health objectives. This distinctive instrument correlates food, beverage, and supplement consumption with essential health indicators, amalgamating data from blood biomarkers, DNA assessments, and fitness trackers.
• In November 2023, Viome Life Sciences purchased the digital wellness firm Naring Health to augment its personalized medicine portfolio. This acquisition grants Viome access to clinical and molecular data, furthering its objectives in customized health and medicine. Through the incorporation of Naring's patents and intellectual property, Viome broadened its portfolio of tailored healthcare solutions.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Technology
3.2. Snippet by Platform Type
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Individualized Health Requirements and Preventive Emphasis Expansion of the Fuel Market
4.1.2. Restraints
4.1.2.1. Elevated Testing Expenses Present an Obstacle to Widespread Adoption
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainability Analysis
5.6. Industry Trend Analysis
5.7. DMI Opinion
6. By Technology
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Metabolomics*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Genomics
6.4. Transcriptomics
6.5. Proteomics
7. By Platform Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
7.1.2. Market Attractiveness Index, By Platform Type
7.2. Genetic Testing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Biomarker Analysis
7.4. Digital Health Platforms
7.5. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Disease Management*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. General Health & Wellness
8.4. Weight Management
8.5. Others
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.1.2. Market Attractiveness Index, By End-user
9.2. Fitness and Wellness Centers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals and Clinics
9.4. Diagnostic Labs
9.5. Individuals
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Analysis and Y-o-Y Growth Analysis (%), By End-user
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. US
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Analysis and Y-o-Y Growth Analysis (%), By End-user
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Analysis and Y-o-Y Growth Analysis (%), By End-user
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Analysis and Y-o-Y Growth Analysis (%), By End-user
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Analysis and Y-o-Y Growth Analysis (%), By End-user
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Viome Life Sciences*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Thorne HealthTech
12.3. Habit
12.4. DayTwo
12.5. Nutrigenomix
12.6. InsideTracker
12.7. Care/of
12.8. Persona Nutrition
12.9. Xcode Life
12.10. 23andMe
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings